138 related articles for article (PubMed ID: 17350222)
1. Mechanism of action of coumarin and silver(I)-coumarin complexes against the pathogenic yeast Candida albicans.
Thati B; Noble A; Rowan R; Creaven BS; Walsh M; McCann M; Egan D; Kavanagh K
Toxicol In Vitro; 2007 Aug; 21(5):801-8. PubMed ID: 17350222
[TBL] [Abstract][Full Text] [Related]
2. In vitro anti-tumour and cyto-selective effects of coumarin-3-carboxylic acid and three of its hydroxylated derivatives, along with their silver-based complexes, using human epithelial carcinoma cell lines.
Thati B; Noble A; Creaven BS; Walsh M; McCann M; Kavanagh K; Devereux M; Egan DA
Cancer Lett; 2007 Apr; 248(2):321-31. PubMed ID: 16996681
[TBL] [Abstract][Full Text] [Related]
3. Erythromycin, an inhibitor of mitoribosomal protein biosynthesis, alters the amphotericin B susceptibility of Candida albicans.
Geraghty P; Kavanagh K
J Pharm Pharmacol; 2003 Feb; 55(2):179-84. PubMed ID: 12631409
[TBL] [Abstract][Full Text] [Related]
4. Disruption of mitochondrial function in Candida albicans leads to reduced cellular ergosterol levels and elevated growth in the presence of amphotericin B.
Geraghty P; Kavanagh K
Arch Microbiol; 2003 Apr; 179(4):295-300. PubMed ID: 12640519
[TBL] [Abstract][Full Text] [Related]
5. Tea polyphenol epigallocatechin-3-gallate inhibits ergosterol synthesis by disturbing folic acid metabolism in Candida albicans.
Navarro-Martínez MD; García-Cánovas F; Rodríguez-López JN
J Antimicrob Chemother; 2006 Jun; 57(6):1083-92. PubMed ID: 16585130
[TBL] [Abstract][Full Text] [Related]
6. Membrane raft lipid constituents affect drug susceptibilities of Candida albicans.
Pasrija R; Prasad T; Prasad R
Biochem Soc Trans; 2005 Nov; 33(Pt 5):1219-23. PubMed ID: 16246085
[TBL] [Abstract][Full Text] [Related]
7. Exposure of the yeast Candida albicans to the anti-neoplastic agent adriamycin increases the tolerance to amphotericin B.
O'Keeffe J; Doyle S; Kavanagh K
J Pharm Pharmacol; 2003 Dec; 55(12):1629-33. PubMed ID: 14738588
[TBL] [Abstract][Full Text] [Related]
8. Mode of anti-fungal activity of 1,10-phenanthroline and its Cu(II), Mn(II) and Ag(I) complexes.
Coyle B; Kavanagh K; McCann M; Devereux M; Geraghty M
Biometals; 2003 Jun; 16(2):321-9. PubMed ID: 12572690
[TBL] [Abstract][Full Text] [Related]
9. Antifolates as antimycotics? Connection between the folic acid cycle and the ergosterol biosynthesis pathway in Candida albicans.
Navarro-Martínez MD; Cabezas-Herrera J; Rodríguez-López JN
Int J Antimicrob Agents; 2006 Dec; 28(6):560-7. PubMed ID: 17046206
[TBL] [Abstract][Full Text] [Related]
10. Antifungal activity and mode of action of silver nano-particles on Candida albicans.
Kim KJ; Sung WS; Suh BK; Moon SK; Choi JS; Kim JG; Lee DG
Biometals; 2009 Apr; 22(2):235-42. PubMed ID: 18769871
[TBL] [Abstract][Full Text] [Related]
11. Metal complexes of 1,10-phenanthroline-5,6-dione alter the susceptibility of the yeast Candida albicans to amphotericin B and miconazole.
Eshwika A; Coyle B; Devereux M; McCann M; Kavanagh K
Biometals; 2004 Aug; 17(4):415-22. PubMed ID: 15259362
[TBL] [Abstract][Full Text] [Related]
12. Damage to the cytoplasmic membrane and cell death caused by lycopene in Candida albicans.
Sung WS; Lee IS; Lee DG
J Microbiol Biotechnol; 2007 Nov; 17(11):1797-804. PubMed ID: 18092463
[TBL] [Abstract][Full Text] [Related]
13. Silver nanoparticles induce apoptotic cell death in Candida albicans through the increase of hydroxyl radicals.
Hwang IS; Lee J; Hwang JH; Kim KJ; Lee DG
FEBS J; 2012 Apr; 279(7):1327-38. PubMed ID: 22324978
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, characterisation and antimicrobial activity of copper(II) and manganese(II) complexes of coumarin-6,7-dioxyacetic acid (cdoaH2) and 4-methylcoumarin-6,7-dioxyacetic acid (4-MecdoaH2): X-ray crystal structures of [Cu(cdoa)(phen)2].8.8H(2)O and [Cu(4-Mecdoa)(phen)2].13H2O (phen=1,10-phenanthroline).
Creaven BS; Egan DA; Karcz D; Kavanagh K; McCann M; Mahon M; Noble A; Thati B; Walsh M
J Inorg Biochem; 2007 Aug; 101(8):1108-19. PubMed ID: 17555821
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of amino acid appended indoles: appreciable anti-fungal activity and inhibition of ergosterol biosynthesis as their probable mode of action.
Pooja ; Prasher P; Singh P; Pawar K; Vikramdeo KS; Mondal N; Komath SS
Eur J Med Chem; 2014 Jun; 80():325-39. PubMed ID: 24794769
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of ergosterol synthesis by novel antifungal compounds targeting C-14 reductase.
Hata M; Ishii Y; Watanabe E; Uoto K; Kobayashi S; Yoshida K; Otani T; Ando A
Med Mycol; 2010 Jun; 48(4):613-21. PubMed ID: 20392153
[TBL] [Abstract][Full Text] [Related]
17. Punicalagin triggers ergosterol biosynthesis disruption and cell cycle arrest in Cryptococcus gattii and Candida albicans : Action mechanisms of punicalagin against yeasts.
Silva TC; de Ávila RI; Zara ALSA; Santos AS; Ataídes F; Freitas VAQ; Costa CR; Valadares MC; Silva MDRR
Braz J Microbiol; 2020 Dec; 51(4):1719-1727. PubMed ID: 32856241
[TBL] [Abstract][Full Text] [Related]
18. Novel silver(I) complexes of coumarin oxyacetate ligands and their phenanthroline adducts: Biological activity, structural and spectroscopic characterisation.
Mujahid M; Trendafilova N; Arfa-Kia AF; Rosair G; Kavanagh K; Devereux M; Walsh M; McClean S; Creaven BS; Georgieva I
J Inorg Biochem; 2016 Oct; 163():53-67. PubMed ID: 27522552
[TBL] [Abstract][Full Text] [Related]
19. Respiratory deficiency enhances the sensitivity of the pathogenic fungus Candida to photodynamic treatment.
Chabrier-Roselló Y; Foster TH; Mitra S; Haidaris CG
Photochem Photobiol; 2008; 84(5):1141-8. PubMed ID: 18248505
[TBL] [Abstract][Full Text] [Related]
20. Antifungal Activity of Coumarin Against
Jia C; Zhang J; Yu L; Wang C; Yang Y; Rong X; Xu K; Chu M
Front Cell Infect Microbiol; 2018; 8():445. PubMed ID: 30662877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
